Should You Buy NuScale While It's Below $15?

NuScale Power’s stock price hovering below $15 amid a 26% decline this year isn’t just another market fluctuation—it signals deeper struggles within the nuclear energy sector’s high-stakes push to modernize. The company, once hailed as a pioneer in small modular reactor (SMR) technology, now faces a credibility gap as legal challenges and waning investor confidence erode its financial footing. With roughly $1 billion in cash reserves, NuScale’s survival hinges on whether it can pivot from developmental setbacks to commercial viability, but the path forward remains perilous. The broader significance of this moment extends beyond a single stock: it reflects the broader tension between technological ambition and economic reality in the energy transition. Behind NuScale’s troubles lies a history of overpromising and underdelivering. The company’s SMR design won early regulatory approval, positioning it as a potential game-changer for carbon-free baseload power. Yet, despite securing government funding and partnerships, NuScale has struggled to secure firm customer commitments. Its most high-profile project, a planned six-reactor plant in Idaho, collapsed last year after cost estimates ballooned to nearly $9 billion—far exceeding initial projections. Legal disputes with utilities and subcontractors have further strained resources, while competition in the SMR space intensifies with rivals like TerraPower and Westinghouse advancing their own designs. For investors, the question isn’t just whether NuScale’s technology will work, but whether it can do so at a price point that justifies its existence in an energy market increasingly dominated by cheaper renewables and natural gas. What happens next depends on whether NuScale can restructure its debts, renegotiate contracts, or find new backers willing to bet on its long-term potential. The company’s ability to secure additional funding—or face further dilution—will determine if it survives as an independent entity or becomes an acquisition target. For the SMR industry, NuScale’s struggles serve as a cautionary tale about the risks of scaling new nuclear technologies before the economics are proven. With global decarbonization goals looming, the stakes couldn’t be higher: if NuScale fails, it may chill investment in next-generation nuclear precisely when the world needs it most.